Erwin Troxler
Director of Finance/CFO chez HBM HEALTHCARE INVESTMENTS AG
Fortune : 1 M $ au 31/03/2024
Postes actifs de Erwin Troxler
Sociétés | Poste | Début | Fin |
---|---|---|---|
HBM HEALTHCARE INVESTMENTS AG | Director of Finance/CFO | 01/11/2011 | - |
Schweizer Verband der Investmentgesellschaften | Chairman | 01/01/2014 | - |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Director of Finance/CFO | 01/01/2005 | - |
Historique de carrière de Erwin Troxler
Statistiques
Internationale
Suisse | 4 |
Opérationnelle
Director of Finance/CFO | 2 |
Chairman | 1 |
Sectorielle
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Finance |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
Schweizer Verband der Investmentgesellschaften |
- Bourse
- Insiders
- Erwin Troxler
- Expérience